Imax (IMAX) Research & Development (2010 - 2026)

Imax (IMAX) has reported Research & Development for 17 consecutive years, with $1.7 million the latest figure, recorded in Q2 2026.

• Quarterly Research & Development rose 7.33% year-over-year to $1.7 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $6.4 million (up 71.3% YoY) and the FY2025 annual result came in at $5.8 million, up 13.97% from the prior year.
• Research & Development retreated to $1.7 million in Q2 2026 per IMAX's latest filing, from $1.8 million in the prior quarter.
• Over the last five years, Research & Development for IMAX reached as high as $2.8 million in Q3 2023 and fell as low as -$265000.0 in Q3 2024.
• A 5-year average of $1.7 million and a median of $1.6 million in 2022 frame the typical range for Research & Development.
• Annual changes were most pronounced in 2024 — Research & Development plunged 109.56% — and 2025, when it soared 667.92%.
• Year by year, Research & Development stood at $1.6 million in 2022, then jumped by 66.69% to $2.7 million in 2023, then slumped by 57.75% to $1.2 million in 2024, then climbed by 26.17% to $1.5 million in 2025, then gained by 14.06% to $1.7 million in 2026.
• According to Business Quant data, Research & Development over the past three periods registered $1.7 million, $1.8 million, and $1.5 million for Q2 2026, Q1 2026, and Q4 2025 respectively.